Precision Nanomedicine · Sub-20nm Deciparticle™ Platform · Global Development

Sapu Nano develops sub-20nm Deciparticle™ therapeutics engineered for deeper tumor penetration, improved biodistribution, and optimized systemic exposure. Our platform supports next-generation oncology medicines, with programs advancing through early- and late-stage clinical development across solid tumors and rare pediatric diseases.